Tekcapital plc Belluscura PLC Expands its Patent Portfolio
17 Settembre 2018 - 8:01AM
RNS Non-Regulatory
TIDMTEK
Tekcapital plc
17 September 2018
17 September 2018
Tekcapital plc
("Tekcapital" or the "Company")
Belluscura PLC Expands its Patent Portfolio
Tekcapital plc (AIM: TEK), the UK intellectual property (IP)
investment group focused on creating marketplace value from
university technology, announces that its portfolio company
Belluscura plc ("Belluscura") has expanded its patent
portfolio.
Belluscura PLC in conjunction with its exclusive research
partner Separation Design Group, announced today the recent filing
of three patent applications and the receipt of a Notice of
Allowance of a fourth application in the fields of respiratory,
postoperative recovery, sedation/sleep monitoring and artificial
intelligence.
The latest patent application, titled "System and method for
improving patient recovery postoperatively," involves the combining
of artificial intelligence and deep learning with Belluscura's
patented oxygen enrichment and sleep technology to improve patient
postoperative recovery and reduce hospital readmission.
Belluscura now owns or exclusively licenses 15 patents and
applications in the respiratory, sedation/sleep monitoring and
artificial intelligence (AI) fields.
Commenting on the patenting activities, Bob Rauker, CEO of
Belluscura, said, "We are very excited about our next generation
technology. It is estimated that patient readmissions in the US
alone cost Medicare $27bn per year. Incorporating AI into our
leading-edge oxygen enrichment technology opens up additional
markets in postoperative recovery beyond the current rapidly
growing $1.2bn portable oxygen concentrator market."
Dr. Clifford Gross, Chairman at Tekcapital commented: "We are
delighted with Belluscura's reported progress on the development of
its intellectual property."
About Belluscura PLC
Belluscura plc is an English company that is focused on
improving healthcare and people's lives by developing new and
innovative treatment platforms. They license and develop
proprietary technologies that can be applied across a range of
treatment possibilities. For additional information, please visit
www.belluscura.com.
For further information, please contact:
Tekcapital plc Via Walbrook PR
Clifford M Gross, Ph.D.
finnCap Ltd (Nominated Adviser
and Joint Broker) + 44 (0) 20 7220 0500
Geoff Nash / Max Bullen-Smith (Corporate
Finance)
Alice Lane (ECM)
Novum Securities Limited (Joint
Broker) +44 (0) 20 7399 9427
Colin Rowbury (Corporate Broking)
Walbrook PR Ltd +44 (0) 20 7933 8780
Paul Cornelius / Sam Allen / Nick tekcapital@walbrookpr.com
Rome
Tekcapital plc - The World's Largest University Network for Open
Innovation
Tekcapital's objective is to create value from investing in new,
university-developed intellectual properties. Additionally, using
its proprietary discovery search engine, linked to 4,500+
universities in 160 countries, coupled with expert scientific
review, Tekcapital provides a range of IP investment services to
make it easy for organisations to find, evaluate, acquire and
license university-developed technology. Tekcapital plc is quoted
on the AIM market of the London Stock Exchange (AIM: symbol TEK)
and is headquartered in Oxford, in the UK. For more information,
please visit www.tekcapital.com
LEI: 213800GOJTOV19FIFZ85
This Press Release contains forward-looking statements that
involve substantial risks and uncertainties, and actual results and
developments may differ materially from those expressed or implied
by these statements. These forward-looking statements are
statements regarding the Company's intentions, beliefs or current
expectations concerning, among other things, the Company's results
of operations, financial condition, prospects, growth, strategies
and the industry in which the Company operates. By their nature,
forward-looking statements involve risks and uncertainties because
they relate to events and depend on circumstances that may or may
not occur in the future. These forward-looking statements speak
only as of the date of this Press Release and the Company does not
undertake any obligation to publicly release any revisions to these
forward-looking statements to reflect events or circumstances after
the date of this Press Release.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NRAGMGMLKDMGRZM
(END) Dow Jones Newswires
September 17, 2018 02:01 ET (06:01 GMT)
Grafico Azioni Tekcapital (LSE:TEK)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Tekcapital (LSE:TEK)
Storico
Da Lug 2023 a Lug 2024